Jeff Goad, PharmD, MPH, joined Over the Counter to discuss ongoing developments regarding COVID-19 vaccines and the future of mRNA technology.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; joined Over the Counter to discuss direct-to-patient pharmacy models and how they're revolutionizing the future of health care.

Jesse Dresser, Esq, joined Over the Counter to provide necessary insights into recently signed PBM reform set to revolutionize the distribution of pharmacy benefits.

Alyssa Billingsley, PharmD, joined Over the Counter to discuss the FDA's prescription to OTC transition process and what recent switches mean for independent pharmacies and their patients.

Chad Worz, PharmD, BCGP, FASCP, and James Lewis, from the American Society of Consultant Pharmacists (ASCP), joined Over the Counter to discuss the Inflation Reduction Act's industry-wide changes kicking off in 2026.

Meagan Brown, PharmD, BCACP, joined Over the Counter to celebrate National Pharmacist Day and discuss the various avenues for expanding pharmacists' scope.

Susan Thomas, RN, joined Over the Counter to discuss women's health, the pharmacist's role, and her organization's newly launched program designed to benefit both patients and providers.

Jennifer Flynn, CPHRM, joined Over the Counter to discuss pharmacists' potential risks and benefits when using social media for professional or personal purposes.

Kenric B. Ware, PharmD, MBA, AAHIVP, joined Over the Counter to discuss stigmas surrounding HIV care and prevention as well as the pharmacist's role in advancing management of the condition.

Ron Lanton III, Esq, joined Over the Counter to discuss the Most Favored Nation drug pricing policy and what exactly it may mean for stakeholders heading into 2026.